H&H Calls 15 May 2026 AGM; Board Seeks Approval for HK$0.16 Final Dividend, 20% Issue Mandate and 10% Buy-Back Authority

Bulletin Express
Apr 10

Health and Happiness (H&H) International Holdings Limited (abbreviated as H&H) has issued a notice convening its 2026 Annual General Meeting (AGM) for 15 May 2026 at 9:30 a.m. in Central, Hong Kong.

Key resolutions to be tabled:

1. FY25 Results & Dividend • Shareholders will vote on adopting the audited consolidated financial statements for the year ended 31 December 2025. • The Board recommends a final dividend of HK$0.16 per ordinary share, to be funded from retained profits. • The share register will be closed from 21 May 2026 to 26 May 2026 (both days inclusive). The record date for dividend entitlement is 26 May 2026.

2. Board Composition & Remuneration • Re-election of three directors: non-executive director Mrs Laetitia Albertini and independent non-executive directors Mrs Lok Lau Yin Ching and Professor Ding Yuan. • Authorisation for the Board to determine directors’ remuneration.

3. Auditor Re-appointment • Proposal to re-appoint Ernst & Young as external auditor for the next financial year and authorise the Board to fix its remuneration.

4. Capital Management Mandates • General mandate permitting the Board to issue and deal with new shares—up to 20% of the Company’s issued share capital (excluding treasury shares) at the date of the AGM. • Share buy-back mandate allowing repurchase of up to 10% of the issued share capital. • An extension mandate to increase the share-issue limit by the number of shares actually repurchased, capped at an additional 10%.

5. Meeting Logistics • The share register will be closed from 12 May 2026 to 15 May 2026 for determining AGM voting eligibility; the record date is 15 May 2026. • All resolutions will be decided by poll, with results published on the Hong Kong Exchanges and Clearing Limited (HKEX) website. • Proxy forms must be lodged with Computershare Hong Kong Investor Services Limited no later than 9:30 a.m. on 13 May 2026.

As at the notice date, H&H’s Board comprises two executive directors (Mr Luo Fei and Mr Wang Yidong), four non-executive directors and three independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10